Prange Pharma has completed its acquisition of MSD Animal Health’s Aprilia site in Italy, which will now operate as Aprilia Animal Health, a new European CDMO platform for the animal health sector.
Prange Pharma is taking over a production site from MSD Animal Health in Aprilia, Italy. A new center for contract manufacturing in the field of animal health products is to be established there.
EuroAPI has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company.
MSD Animal Health, a division of Merck & Co., announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for €1.2 billion ($1.3 billion) in cash. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions.
